TFPI: Tissue factor pathway inhibitor
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Inhibits factor X (X(a)) directly and, in a Xa-dependent way, inhibits VIIa/tissue factor activity, presumably by forming a quaternary Xa/LACI/VIIa/TF complex.
- Drugs that act on it: 4
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Marstacimab | Approved | Tissue factor pathway inhibitor inhibitor | Inhibitor | — |
| Andexanet alfa | — | Tissue factor pathway inhibitor inhibitor | Inhibitor | Boxed warning |
| BAY-1093884 | — | Tissue factor pathway inhibitor inhibitor | Inhibitor | — |
| Concizumab | — | Tissue factor pathway inhibitor inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Hemophilia A
- 0.55
- Hemophilia B
- 0.53
- Hemorrhage
- 0.53
- Neurodegenerative disease
- 0.36
- Hemorrhagic disease
- 0.36
- Alzheimer disease
- 0.32
- Parkinson disease
- 0.32
- Lysosomal storage disease
- 0.32
- Endometriosis
- 0.31
- Hemophilia
- 0.29
Drugs and mechanisms are from ChEMBL CHEMBL3713062 (CC BY-SA 3.0). Gene name, function (UniProt P10646, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets